During the past decade, Univerzitna nemocnica Bratislava conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 21 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univerzitna nemocnica Bratislava" #1 sponsor was "Pfizer" with 10 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Ipsen" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univerzitna nemocnica Bratislava" #1 collaborator was "Comenius University" with 2 trials as a collaborator, "University Hospital Bratislava" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Univerzitna nemocnica Bratislava" are "Ulcerative Colitis" (6 trials), "Alzheimer Disease" (4 trials), "Acromegaly" (2 trials), "Cardiovascular Disease" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Univerzitna nemocnica Bratislava" in a lesser frequency.

Most popular intervention types in "Univerzitna nemocnica Bratislava" are "Drug" (36 trials), "Other" (9 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Botulinum toxin type A" (3 trials), "placebo" (3 trials), "Aflibercept" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Univerzitna nemocnica Bratislava" are 44 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 10 active trials in "Univerzitna nemocnica Bratislava". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in Univerzitna nemocnica Bratislava, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Univerzitna nemocnica Bratislava, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

Univerzitna nemocnica Bratislava has several departments that took part in Clinical trials: "UN Bratislava Nemocnica Sv. Cyrila a Metoda, kardiologicka ambulancia 1" - 2 trials, "UN Bratislava Nemocnica Ruzinov; Neurologicka klinika" - 2 trials